Rabea Mecklenbrauck

Rabea Mecklenbrauck is a Postdoctoral Researcher at the Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, where she contributes to the Vyas Group's research on the biology and treatment of human myeloid cancers.

Her expertise spans:

• Myeloid Cancers
• Hematology
• Cancer Biology
• Immunology
• Molecular Medicine
• Translational Research

Her work focuses on understanding molecular pathways in blood cancers and immune responses within the context of MRC-funded units at WIMM.

Dr. Mecklenbrauck operates within Oxford's Medical Sciences ecosystem, collaborating with the MRC Molecular Haematology Unit and MRC Translational Immune Discovery Unit to advance therapies for immune-mediated diseases and hematological disorders.